Back to BALPHARMA
Clear

Board Meetings for BALPHARMA

Detailed list of historic and upcoming board meetings.

SymbolCompanyMeeting DatePurposeDescriptionLinks
BALPHARMABal Pharma Limited27 May 2026Board Meeting IntimationBAL PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 27-May-2026 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2026 and Dividend/ESOP/Other business.
PDFXBRL
BALPHARMABal Pharma Limited27 May 2026Financial Results/Dividend/Other business mattersTo consider and approve the audited financial results for the period ended March 31, 2026, dividend and other business matters
PDF
BALPHARMABal Pharma Limited11 Feb 2026Board Meeting IntimationBAL PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 11-Feb-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2025 .
PDFXBRL
BALPHARMABal Pharma Limited11 Feb 2026Financial ResultsTo consider and approve the financial results for the period ended December 31, 2025
PDF
BALPHARMABal Pharma Limited12 Nov 2025Board Meeting IntimationBAL PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 12-Nov-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2025 .
PDFXBRL
BALPHARMABal Pharma Limited12 Nov 2025Financial Results/Other business mattersTo consider and approve the financial results for the period ended September 30, 2025 and other business matters
PDF
BALPHARMABal Pharma Limited11 Aug 2025Financial Results/Other business mattersTo consider and approve the financial results for the period ended Jun 30, 2025 and other business matters
PDF
BALPHARMABal Pharma Limited11 Aug 2025BAL PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 11-Aug-2025 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended June 2025 and ESOP/Amalgamation/Other business.Board Meeting Intimation
PDF
BALPHARMABal Pharma Limited29 May 2025Financial Results/Dividend/Other business mattersTo consider and approve the financial results for the period ended March 31, 2025, dividend and other business matters
PDF
BALPHARMABal Pharma Limited29 May 2025Board Meeting IntimationBAL PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 29-May-2025 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2025 and Dividend/Other business.
PDFXBRL
BALPHARMABal Pharma Limited13 Feb 2025Board Meeting IntimationBAL PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 13-Feb-2025 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended December 2024 and Fund raising.
PDFXBRL
BALPHARMABal Pharma Limited13 Feb 2025Financial Results/Fund RaisingTo consider and approve the financial results for the period ended December 31, 2024 and Fund Raising
PDF
BALPHARMABal Pharma Limited14 Nov 2024Financial Results/Other business mattersTo consider and approve the financial results for the period ended September 30, 2024 and other business matters
PDF
BALPHARMABal Pharma Limited14 Nov 2024Board Meeting IntimationBAL PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 14-Nov-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2024 .
PDF
BALPHARMABal Pharma Limited09 Sept 2024Other business matters1.Allotment of Equity Shares to the employees of the Company upon conversion of stock options vested on them.2. To consider expanding its manufacturing presence to meet the growing demand for Active Pharma Ingredients ( API's)3.Any other matter incidental to the business operations and ensuing Annual General Meeting of the Company.
PDF
Showing page 1 of 8 (113 total items)
Next